Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic Melanoma
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: Phase I trial to study the effectiveness of combining carboplatin and temozolomide
in treating patients who have unresectable or metastatic melanoma.
Phase:
Phase 1
Details
Lead Sponsor:
Mount Vernon Cancer Centre at Mount Vernon Hospital